$2.52
+0.23
(+10.04%)▲
10.32%
Downside
Day's Volatility :10.32%
Upside
0.0%
12.3%
Downside
52 Weeks Volatility :80.27%
Upside
77.5%
Period | Golden Sun Health Technology Group | Index (Russel 2000) |
---|---|---|
3 Months | -65.48% | 0.0% |
6 Months | -13.1% | 0.0% |
1 Year | -58.55% | 0.0% |
3 Years | -98.45% | -27.4% |
Market Capitalization | 4.5M |
Book Value | $1.33 |
Earnings Per Share (EPS) | -2.01 |
Profit Margin | -61.08% |
Operating Margin TTM | -32.05% |
Return On Assets TTM | -10.74% |
Return On Equity TTM | -85.78% |
Revenue TTM | 6.3M |
Revenue Per Share TTM | 3.26 |
Quarterly Revenue Growth YOY | 5.1% |
Gross Profit TTM | 4.8M |
EBITDA | -3.1M |
Diluted Eps TTM | -2.01 |
Quarterly Earnings Growth YOY | -0.74 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 15.2M | - |
Net Income | 3.4M | - |
Net Profit Margin | 22.19% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 14.0M | ↓ 7.95% |
Net Income | 42.0K | ↓ 98.75% |
Net Profit Margin | 0.3% | ↓ 21.89% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 15.0M | ↑ 7.65% |
Net Income | 1.3M | ↑ 3009.57% |
Net Profit Margin | 8.69% | ↑ 8.39% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 10.8M | ↓ 28.03% |
Net Income | -2.1M | ↓ 262.16% |
Net Profit Margin | -19.59% | ↓ 28.28% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 6.2M | ↓ 43.08% |
Net Income | -5.8M | ↑ 173.15% |
Net Profit Margin | -94.0% | ↓ 74.41% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 3.6M | - |
Net Income | -2.5M | - |
Net Profit Margin | -68.48% | - |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.3M | - |
Net Income | -1.1M | - |
Net Profit Margin | -80.33% | - |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.3M | ↑ 0.0% |
Net Income | -1.1M | ↑ 0.0% |
Net Profit Margin | -80.33% | ↑ 0.0% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.6M | ↑ 100.0% |
Net Income | -2.1M | ↑ 100.0% |
Net Profit Margin | -80.33% | ↑ 0.0% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 3.7M | ↑ 41.04% |
Net Income | -1.8M | ↓ 16.72% |
Net Profit Margin | -47.43% | ↑ 32.9% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 14.1M | - |
Total Liabilities | 21.2M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 17.4M | ↑ 23.53% |
Total Liabilities | 24.8M | ↑ 17.05% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.6M | ↓ 61.96% |
Total Liabilities | 14.3M | ↓ 42.48% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 23.4M | ↑ 253.21% |
Total Liabilities | 14.7M | ↑ 3.01% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 19.4M | ↓ 17.03% |
Total Liabilities | 15.1M | ↑ 2.49% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 23.4M | ↑ 0.0% |
Total Liabilities | 14.7M | ↑ 0.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 21.6M | ↓ 8.0% |
Total Liabilities | 15.0M | ↑ 2.1% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 19.4M | ↓ 9.81% |
Total Liabilities | 15.1M | ↑ 0.38% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 19.4M | ↑ 0.0% |
Total Liabilities | 15.1M | ↑ 0.0% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 19.4M | ↑ 0.0% |
Total Liabilities | 15.1M | ↑ 0.0% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 16.4M | ↓ 15.47% |
Total Liabilities | 13.9M | ↓ 7.99% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 6.8M | - |
Investing Cash Flow | -592.5K | - |
Financing Cash Flow | -4.0M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.2M | ↓ 82.83% |
Investing Cash Flow | -1.6M | ↑ 166.69% |
Financing Cash Flow | 360.6K | ↓ 108.92% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 31.9K | ↓ 97.27% |
Investing Cash Flow | -212.6K | ↓ 86.55% |
Financing Cash Flow | -2.0M | ↓ 655.69% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 910.3K | ↑ 2754.08% |
Investing Cash Flow | -174.1K | ↓ 18.13% |
Financing Cash Flow | 18.6M | ↓ 1030.05% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.7M | ↑ 0.0% |
Investing Cash Flow | -2.3M | ↑ 0.0% |
Financing Cash Flow | 223.6K | ↑ 0.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.7M | ↑ 0.0% |
Investing Cash Flow | -2.3M | ↑ 0.0% |
Financing Cash Flow | 223.6K | ↑ 0.0% |
Sell
Neutral
Buy
Golden Sun Health Technology Group is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Golden Sun Health Technology Group | -44.86% | -13.1% | -58.55% | -98.45% | -98.45% |
New Oriental Education & Tech Group Inc | -22.23% | -26.34% | -5.59% | 193.22% | -48.86% |
Grand Canyon Education Inc | 2.36% | 1.04% | 2.83% | 69.56% | 52.1% |
Stride Inc | 21.07% | 32.62% | 68.48% | 163.91% | 371.26% |
Graham Holdings | 8.09% | 15.4% | 38.96% | 44.61% | 36.67% |
Tal Education Group | 2.29% | -11.57% | 27.13% | 184.11% | -73.4% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Golden Sun Health Technology Group | 45.6 | NA | NA | 0.0 | -0.86 | -0.11 | NA | 1.33 |
New Oriental Education & Tech Group Inc | 27.13 | 27.13 | 1.03 | 2.59 | 0.1 | 0.04 | 0.01 | 24.07 |
Grand Canyon Education Inc | 18.63 | 18.63 | 1.03 | 7.99 | 0.31 | 0.18 | NA | 26.05 |
Stride Inc | 16.92 | 16.92 | 0.72 | 4.53 | 0.22 | 0.1 | NA | 28.34 |
Graham Holdings | 16.49 | 16.49 | 0.0 | 52.75 | 0.06 | 0.03 | 0.01 | 924.02 |
Tal Education Group | 95.83 | 95.83 | 1.47 | 0.07 | 0.02 | 0.0 | NA | 6.21 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Golden Sun Health Technology Group | NA | $4.5M | -98.45% | 45.6 | -61.08% |
New Oriental Education & Tech Group Inc | Buy | $10.4B | -48.86% | 27.13 | 8.38% |
Grand Canyon Education Inc | Buy | $4.0B | 52.1% | 18.63 | 21.88% |
Stride Inc | Buy | $4.1B | 371.26% | 16.92 | 11.38% |
Graham Holdings | Sell | $3.7B | 36.67% | 16.49 | 4.86% |
Tal Education Group | Buy | $6.7B | -73.4% | 95.83 | 3.94% |
Insights on Golden Sun Health Technology Group
In the last 1 year, Stride Inc has given 68.5% return, outperforming this stock by 127.1%
UBS Group AG
Organization | Golden Sun Health Technology Group |
Employees | 336 |
CEO | Mr. Xueyuan Weng |
Industry | Services |
Sunlands Online Education Group
$2.52
+10.04%
Anywhere Real Estate Inc
$2.52
+10.04%
Telecom Argentina S.a.
$2.52
+10.04%
Noodles & Co
$2.52
+10.04%
Sonder Holdings Inc
$2.52
+10.04%
Gh Research Plc
$2.52
+10.04%
Gladstone Land Corporation
$2.52
+10.04%
Rumbleon Inc
$2.52
+10.04%
E. W. Scripps Company, Class A Shares
$2.52
+10.04%